Pulmonary arterial hypertension causes the small lung arteries to become narrow, stiff, or thickened. PAH is often idiopathic ...

Results: Five hundred seventy-nine patients were studied, 205 with PPH and 374 with pulmonary hypertension from other causes (secondary pulmonary hypertension [SPH]). The use of anorexigens was ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

distinguishing it from the emphysematous changes seen with chronic obstructive pulmonary disease (COPD).

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

A new treatment, Sotatercept, for pulmonary arterial hypertension (PAH) has recently been approved by the MHRA ...

Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...

MSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as ...